Worth reading
63In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
24.1
% (year-on-year increase in net sales)Wording
Conditional
How definitive the wording is.Contents of this document
Financial results presentationSecond quarter of the fiscal year ending March 202611 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥5,123 million+24.1%
Operating profit¥103 million-56.0%
Ordinary income¥100 million-58.2%
Net income¥-10 million
Gross Profit Margin58.6%
Operating profit margin2.0%
Results for the three months of the current quarter
Net Sales
¥2,571 million+21.9%
Gross profit
¥1,508 million+41.2%
EBITDA
¥190 million-5.1%
Operating profit
¥32 million-75.9%
Ordinary income
¥45 million-67.5%
Net income
¥11 million-89.3%
Full-year earnings forecast
Net Sales
¥11,000 million
EBITDA
¥1,200 million
Operating profit
¥610 million
Ordinary income
¥560 million
Net income
¥320 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales46.6%
EBITDA30.0%
Operating profit17.0%
Ordinary income17.9%
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
売上高は概ね想定通りの進捗。EBITDA以下の利益は進捗率17〜30%。Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
メディカル事業の成長、メディア事業の広告単価下落、ダイエット立ち上げに伴う広告宣伝費、特別損失101百万円(本社移転費用68百万円、事業撤退損33百万円)、人件費37百万円増
New initiatives
- FanGrowth Studioの提供開始
- 不採算メディアサービスの終了と外注費・業務委託費等の固定費削減
- 10ギガ回線の強化
- FanGrowthを中心とするエンタープライズ向けプロダクトの投入
- 自己株式取得による流通株式比率の増加と株主還元
Key KPIsA metric the company considers important as a management benchmark.
- ONE MEDICAL月間GMV337百万円(10月)
- カウンセリングサービス相談回数Year on year against the same period last year7.5%減
- Repeat customer ratio69.2 %
- Average monthly page views for Media ServicesYear on year against the same period last yearDown 18.7%
- 主要光回線サービス・MVNO月間平均課金会員数60,885 peopleYear on year against the same period last yearDown 3.3% year on year
- SaaS business ARR¥489 millionYear on year against the same period last year21.3%増
Unit price and quantity metricsThese figures show sales broken down by price and volume.
カウンセリング相談回数、メディア平均PV数、広告単価、光回線等の課金会員数が示されている。客数と客単価等の一組の定量分解はNot disclosed。Segment results
Medical Business
Net Sales612百万円(前年同期比1,026.6%増)
Operating profit▲83百万円(前年同期比83百万円減)
Platform Business
Net Sales845百万円(前年同期比7.1%減)
Operating profit125百万円(前年同期比26.7%減)
Broadband business
Net Sales899百万円(前年同期比3.9%減)
Operating profit130百万円(前年同期比12.2%減)
SaaS and DX Business
Net Sales214百万円(前年同期比2.0%増)
Operating profit▲28百万円(前年同期比10百万円増)
Financial targets
連結株主資本配当率(DOE)4%を目安とする方針。自己資本比率の実績は32.7%。Market Size / Share
美容医療市場規模約6,300億円。2024年インターネット広告費3.6兆円、総広告費に占める割合47.6%。Number of employees
連結263名(2025年9月末、契約・アルバイト社員含む)。期中増減・採用計画はNot disclosed。Annual Dividend
31.5円(普通配当31.5円)。中間・期末の内訳はNot disclosed。Acquisition of treasury shares
74,000株、97百万円、発行済株式総数の1.75%。取得日は9月2日。取得期間の記載はNot disclosed。| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2026 |
| Net Sales | ¥5,123 million (YoY +24.1%) |
| Operating profit | ¥103 million (YoY -56.0%) |
| Ordinary income | ¥100 million (YoY -58.2%) |
| Net income | ¥-10 million |
| Gross Profit Margin | 58.6% |
| Operating profit margin | 2.0% |
| Results for the three months of the current quarter | Net Sales ¥2,571 million (YoY +21.9%) / Gross profit ¥1,508 million (YoY +41.2%) / EBITDA ¥190 million (YoY -5.1%) / Operating profit ¥32 million (YoY -75.9%) / Ordinary income ¥45 million (YoY -67.5%) / Net income ¥11 million (YoY -89.3%) |
| Full-year earnings forecast | Net Sales ¥11,000 million / EBITDA ¥1,200 million / Operating profit ¥610 million / Ordinary income ¥560 million / Net income ¥320 million |
| Progress against full-year forecast | Net Sales 46.6% / EBITDA 30.0% / Operating profit 17.0% / Ordinary income 17.9% / Net income Not disclosed |
| Self-assessment against the plan | 売上高は概ね想定通りの進捗。EBITDA以下の利益は進捗率17〜30%。 |
| Segment results | Medical Business Net Sales 612百万円(前年同期比1,026.6%増) / Operating profit ▲83百万円(前年同期比83百万円減) / Platform Business Net Sales 845百万円(前年同期比7.1%減) / Operating profit 125百万円(前年同期比26.7%減) / Broadband business Net Sales 899百万円(前年同期比3.9%減) / Operating profit 130百万円(前年同期比12.2%減) / SaaS and DX Business Net Sales 214百万円(前年同期比2.0%増) / Operating profit ▲28百万円(前年同期比10百万円増) |
| Breakdown of Factors Affecting the Change | メディカル事業の成長、メディア事業の広告単価下落、ダイエット立ち上げに伴う広告宣伝費、特別損失101百万円(本社移転費用68百万円、事業撤退損33百万円)、人件費37百万円増 |
| Key KPIs | Indicator name ONE MEDICAL月間GMV / Value 337百万円(10月) / Year on year against the same period last year Not disclosed, Indicator name カウンセリングサービス相談回数 / Value Not disclosed / Year on year against the same period last year 7.5%減, Indicator name Repeat customer ratio / Value 69.2 % / Year on year against the same period last year Not disclosed, Indicator name Average monthly page views for Media Services / Value Not disclosed / Year on year against the same period last year Down 18.7%, Indicator name 主要光回線サービス・MVNO月間平均課金会員数 / Value 60,885 people / Year on year against the same period last year Down 3.3% year on year, Indicator name SaaS business ARR / Value ¥489 million / Year on year against the same period last year 21.3%増 |
| Unit price and quantity metrics | カウンセリング相談回数、メディア平均PV数、広告単価、光回線等の課金会員数が示されている。客数と客単価等の一組の定量分解はNot disclosed。 |
| Number of employees | 連結263名(2025年9月末、契約・アルバイト社員含む)。期中増減・採用計画はNot disclosed。 |
| Financial targets | 連結株主資本配当率(DOE)4%を目安とする方針。自己資本比率の実績は32.7%。 |
| Annual Dividend | 31.5円(普通配当31.5円)。中間・期末の内訳はNot disclosed。 |
| Acquisition of treasury shares | 74,000株、97百万円、発行済株式総数の1.75%。取得日は9月2日。取得期間の記載はNot disclosed。 |
| Market Size / Share | 美容医療市場規模約6,300億円。2024年インターネット広告費3.6兆円、総広告費に占める割合47.6%。 |
| New initiatives | FanGrowth Studioの提供開始, 不採算メディアサービスの終了と外注費・業務委託費等の固定費削減, 10ギガ回線の強化, FanGrowthを中心とするエンタープライズ向けプロダクトの投入, 自己株式取得による流通株式比率の増加と株主還元 |
Items this document does not state (9)
Selling, general and administrative expensesNumber of stores and locationsAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsPayout ratioCapital expendituresOrders received and order backlogKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.売上高はONE MEDICALを中心とするメディカル事業の成長が寄与した。利益面では、メディア事業の広告単価下落、メディカル事業でのダイエット立ち上げに伴う広告宣伝費、特別損失101百万円の計上が影響した。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.